Lampert EJ - Search Results

1

Phase I/Ib study of olaparib and carboplatin in heavily pretreated recurrent high-grade serous ovarian cancer at low genetic risk.

Lampert EJ, Hays JL, Kohn EC, Annunziata CM, Minasian L, Yu M, Gordon N, Sissung TM, Chiou VL, Figg WD, Houston N, Lee JM. Lampert EJ, et al. Oncotarget. 2019 Apr 23;10(30):2855-2868. doi: 10.18632/oncotarget.26869. eCollection 2019 Apr 23. Oncotarget. 2019. PMID: 31080557 Free PMC article.

2

Targeting the PI3K pathway and DNA damage response as a therapeutic strategy in ovarian cancer.

Huang TT, Lampert EJ, Coots C, Lee JM. Huang TT, et al. Among authors: lampert ej. Cancer Treat Rev. 2020 Jun;86:102021. doi: 10.1016/j.ctrv.2020.102021. Epub 2020 Apr 10. Cancer Treat Rev. 2020. PMID: 32311593 Free PMC article. Review.

3

Combination of PARP Inhibitor Olaparib, and PD-L1 Inhibitor Durvalumab, in Recurrent Ovarian Cancer: a Proof-of-Concept Phase II Study.

Lampert EJ, Zimmer A, Padget M, Cimino-Mathews A, Nair JR, Liu Y, Swisher EM, Hodge JW, Nixon AB, Nichols E, Bagheri MH, Levy E, Radke MR, Lipkowitz S, Annunziata CM, Taube JM, Steinberg SM, Lee JM. Lampert EJ, et al. Clin Cancer Res. 2020 Aug 15;26(16):4268-4279. doi: 10.1158/1078-0432.CCR-20-0056. Epub 2020 May 12. Clin Cancer Res. 2020. PMID: 32398324 Free PMC article. Clinical Trial.

4

Clinical outcomes of prexasertib monotherapy in recurrent BRCA wild-type high-grade serous ovarian cancer involve innate and adaptive immune responses.

Lampert EJ, Cimino-Mathews A, Lee JS, Nair J, Lee MJ, Yuno A, An D, Trepel JB, Ruppin E, Lee JM. Lampert EJ, et al. J Immunother Cancer. 2020 Jul;8(2):e000516. doi: 10.1136/jitc-2019-000516. J Immunother Cancer. 2020. PMID: 32709712 Free PMC article. Clinical Trial.

5

Carving a niche for immunotherapy in ovarian cancer.

Gupta N, Lampert E, Lee JM. Gupta N, et al. Oncotarget. 2021 Jan 5;12(1):4-7. doi: 10.18632/oncotarget.27864. eCollection 2021 Jan 5. Oncotarget. 2021. PMID: 33456707 Free PMC article. No abstract available.

6

BLM overexpression as a predictive biomarker for CHK1 inhibitor response in PARP inhibitor-resistant BRCA-mutant ovarian cancer.

Gupta N, Huang TT, Nair JR, An D, Zurcher G, Lampert EJ, McCoy A, Cimino-Mathews A, Swisher EM, Radke MR, Lockwood CM, Reichel JB, Chiang CY, Wilson KM, Cheng KC, Nousome D, Lee JM. Gupta N, et al. Among authors: lampert ej. Sci Transl Med. 2023 Jun 21;15(701):eadd7872. doi: 10.1126/scitranslmed.add7872. Epub 2023 Jun 21. Sci Transl Med. 2023. PMID: 37343085 Free PMC article. Clinical Trial.

7

Higher incidence of venous thromboembolism associated with increasing lines of treatment in heavily treated ovarian cancer patients.

Lampert EJ, Hansen JL, Tewari S, Yao M, Chambers LM, Vargas R, AlHilli MM. Lampert EJ, et al. Int J Gynecol Cancer. 2024 Aug 5;34(8):1246-1252. doi: 10.1136/ijgc-2024-005735. Int J Gynecol Cancer. 2024. PMID: 39002980

8

Efficacy and toxicity of carboplatin and gemcitabine administered on day 1 and day 8 (day1&8) versus day 1-only for platinum-sensitive recurrent epithelial ovarian cancer.

Lampert EJ, Rose PG, Yao M, DeBernardo R, Vargas RJ, Michener CM, Chambers LM. Lampert EJ, et al. Int J Gynecol Cancer. 2023 Jul 3;33(7):1090-1098. doi: 10.1136/ijgc-2022-004199. Int J Gynecol Cancer. 2023. PMID: 37024239

9

Association of Clinical Trial Participation With Improved Overall Survival for Recurrent, Platinum-Resistant Ovarian Cancer.

Morton M, Yao M, Chalif J, Lampert EJ, Chau D, Rose PG, Debernardo R, Michener CM, Vargas R, Chambers LM. Morton M, et al. Among authors: lampert ej. Obstet Gynecol. 2023 Sep 1;142(3):459-466. doi: 10.1097/AOG.0000000000005298. Obstet Gynecol. 2023. PMID: 37535957

10

Intratumoral and Intertumoral Genomic Heterogeneity of Multifocal Localized Prostate Cancer Impacts Molecular Classifications and Genomic Prognosticators.

Wei L, Wang J, Lampert E, Schlanger S, DePriest AD, Hu Q, Gomez EC, Murakam M, Glenn ST, Conroy J, Morrison C, Azabdaftari G, Mohler JL, Liu S, Heemers HV. Wei L, et al. Eur Urol. 2017 Feb;71(2):183-192. doi: 10.1016/j.eururo.2016.07.008. Epub 2016 Jul 21. Eur Urol. 2017. PMID: 27451135 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

22 results

Search Page

Filters